SII To Sell COVAX COVID-19 Vaccine For Rs 225 Per Dose

The Serum Institute of India (SII) announced that it will sell COVID-19 vaccines developed by the University of Oxford-AstraZeneca and Novavax at Rs 225 per dose after signing an agreement with the Bill and Melinda Gates Foundation and Gavi, The Vaccine Alliance. As per the deal, the Bill and Melinda Gates foundation will provide SII with $150 million in at-risk funds to accelerate the manufacturing process. SII will produce 100 million doses of the potential COVID-19 vaccine for India and other low and middle-income countries.